Skip to main content
Clinical Trials/NCT01340534
NCT01340534
Completed
Phase 3

Supplemental Perioperative Oxygen at 80% FIO2 to Reduce the Incidence of Post-cesarean Wound Infection. A Randomised, Clinical Trial

Saint Thomas Hospital, Panama1 site in 1 country370 target enrollmentOctober 2011

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Surgical Wound Infection
Sponsor
Saint Thomas Hospital, Panama
Enrollment
370
Locations
1
Primary Endpoint
Number of participants with surgical site infection (SSI).
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine if the use of supplemental oxygen at 80% FIO2 can reduce the incidence of surgical site infection after emergency cesarean section.

Detailed Description

Surgical site infection (SSI) is one of the most important complications that can develop after a cesarean section. SSI can be mild or it can develop into septic shock and death, being cesarean section the most important cause of puerperal infections. Supplemental oxygen at high doses has been advocated as a protective factor for SSI. The purpose of this study is to determine if the use of oxygen at high doses (80% FIO2)can reduce the incidence of SSI after emergency cesarean section.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
December 2011
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Saint Thomas Hospital, Panama
Responsible Party
Principal Investigator
Principal Investigator

Osvaldo A. Reyes T.

Coordinator of Development and Research

Saint Thomas Hospital, Panama

Eligibility Criteria

Inclusion Criteria

  • Gestational age \> 37 weeks
  • Emergency cesarean section
  • Regional Anesthesia

Exclusion Criteria

  • Elective cesarean section
  • Fever of unknown origin at admission
  • Twin pregnancy
  • Chorioamnionitis
  • Acute fetal distress that requires general anesthesia
  • Immunocompromise
  • Maternal Lung/Respiratory Disease

Outcomes

Primary Outcomes

Number of participants with surgical site infection (SSI).

Time Frame: 2 months

The patients will be evaluated for evidence of surgical site infection before leaving the hospital, at 15 and 30 days post surgery. The presence of fever, supurative secretion through the wound or cutaneous changes compatible witn infection will be considered a surgical site infection (SSI). This outcome will be evaluated with a qualitative variable (presence of SSI). The patients will be clasiffied in accordance as "With SSI" or "Without SSI". This will allow us to determine if the use of oxygen at 80% FIO2 can reduce the incidence of SSI.

Secondary Outcomes

  • Number of participants with respiratory complications trans or post surgery.(2 months)

Study Sites (1)

Loading locations...

Similar Trials